177 related articles for article (PubMed ID: 34102009)
1. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
3. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
4. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
5. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis.
Gondim Teixeira PA; Biouichi H; Abou Arab W; Rios M; Sirveaux F; Hossu G; Blum A
Eur Radiol; 2020 Feb; 30(2):895-902. PubMed ID: 31468156
[TBL] [Abstract][Full Text] [Related]
7. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.
Cassidy MR; Lefkowitz RA; Long N; Qin LX; Kirane A; Sbaity E; Hameed M; Coit DG; Brennan MF; Singer S; Crago AM
Ann Surg; 2020 Apr; 271(4):748-755. PubMed ID: 30418203
[TBL] [Abstract][Full Text] [Related]
8. Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
Crombé A; Kind M; Ray-Coquard I; Isambert N; Chevreau C; André T; Lebbe C; Cesne AL; Bompas E; Piperno-Neumann S; Saada E; Bouhamama A; Blay JY; Italiano A;
AJR Am J Roentgenol; 2020 Dec; 215(6):1539-1548. PubMed ID: 32991215
[No Abstract] [Full Text] [Related]
9. MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis.
Subhawong TK; Feister K; Sweet K; Alperin N; Kwon D; Rosenberg A; Trent J; Wilky BA
Radiol Imaging Cancer; 2021 Jul; 3(4):e210016. PubMed ID: 34213370
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.
Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581
[TBL] [Abstract][Full Text] [Related]
11. Oral vinorelbine in young patients with desmoid-type fibromatosis.
Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N
Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926
[TBL] [Abstract][Full Text] [Related]
12. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance imaging of desmoid-type fibromatosis: Current evaluation criteria].
Ben Haj Amor M; Ploton L; Ceugnart L; Taïeb S
Bull Cancer; 2020 Mar; 107(3):359-363. PubMed ID: 32008700
[TBL] [Abstract][Full Text] [Related]
14. The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution.
Zheng C; Zhou Y; Wang Y; Luo Y; Tu C; Min L
Drug Des Devel Ther; 2020; 14():3941-3950. PubMed ID: 33061299
[TBL] [Abstract][Full Text] [Related]
15. The value of the black fiber sign on T1-weighted images for predicting stability of desmoid fibromatosis managed conservatively.
Murahashi Y; Emori M; Shimizu J; Anzai K; Tanaka T; Naka N; Tsuchie H; Nagasawa H; Miyakoshi N; Shimada Y; Yamashita T
Eur Radiol; 2020 Oct; 30(10):5768-5776. PubMed ID: 32435931
[TBL] [Abstract][Full Text] [Related]
16. MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
Shimizu K; Hamada S; Sakai T; Ito S; Urakawa H; Arai E; Ikuta K; Koike H; Ishiguro N; Nishida Y
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):751-757. PubMed ID: 31448875
[TBL] [Abstract][Full Text] [Related]
17. MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients.
Düx DM; Baal JD; Bitton R; Chen J; Brunsing RL; Sheth VR; Rosenberg J; Kim K; Ozhinsky E; Avedian R; Ganjoo K; Bucknor M; Dobrotwir A; Ghanouni P
Eur Radiol; 2024 Feb; 34(2):1137-1145. PubMed ID: 37615768
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
19. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
[TBL] [Abstract][Full Text] [Related]
20. Desmoid-type fibromatosis: Tumour response assessment using magnetic resonance imaging signal and size criteria.
Zhu HC; Li XT; Ji WY; Li S; Sun YS
Clin Imaging; 2020 Dec; 68():111-120. PubMed ID: 32590270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
